Cyberonics raises funds in public offering:
This article was originally published in Clinica
Cyberonics has raised around $48 million in a public offering. The money will boost marketing, fund clinical trials and go towards developing new products. The company's devices treat various conditions through vagus nerve stimulation. The three million shares at $15.875 bring Cyberonics' shares total to 16 million.